C2 C Wealth Management, LLC Bio Rad Laboratories, Inc. Transaction History
C2 C Wealth Management, LLC
- $102 Million
- Q2 2024
A detailed history of C2 C Wealth Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, C2 C Wealth Management, LLC holds 1,725 shares of BIO stock, worth $569,267. This represents 0.46% of its overall portfolio holdings.
Number of Shares
1,725
Previous 1,725
-0.0%
Holding current value
$569,267
Previous $596,000
20.97%
% of portfolio
0.46%
Previous 0.6%
Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
460Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$784 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$512 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$373 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$284 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$218 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.13B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...